XML 90 R77.htm IDEA: XBRL DOCUMENT v3.8.0.1
Capital Stock (Stock Option, Restricted Stock and Restricted Share Unit Activity) (Details)
9 Months Ended
Dec. 31, 2017
$ / shares
shares
Class A Voting Shares | Stock Options and Equity-Settled SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2017 (in shares) | shares 9,089,915
Granted (in shares) | shares 423,667
Options exercised (in shares) | shares (515,337)
Forfeited or expired (in shares) | shares (12,842)
Outstanding at September 30, 2017 (in shares) | shares 8,985,403
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2017, weighted average exercise price (in usd per share) | $ / shares $ 26.67
Granted, weighted average exercise price (in usd per share) | $ / shares 31.32
Options exercised, weighted average exercise price (in usd per share) | $ / shares 19.17
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 34.95
Outstanding at September 30, 2017, weighted average exercise price (in usd per share) | $ / shares $ 27.30
Class A Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2017 (in shares) | shares 519,148
Granted (in shares) | shares 106,767
Restricted stock or RSUs vested (in shares) | shares (346,171)
Forfeited or expired (in shares) | shares (9,566)
Outstanding at September 30, 2017 (in shares) | shares 270,178
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2017, weighted average grant-date fair value (in usd per share) | $ / shares $ 27.85
Granted, weighted average grant date fair value (in usd per share) | $ / shares 29.04
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 28.03
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 32.11
Outstanding at September 30, 2017, weighted average grant-date fair value (in usd per share) | $ / shares $ 27.95
Class B Non-Voting Shares | Stock Options and Equity-Settled SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2017 (in shares) | shares 24,301,704
Granted (in shares) | shares 1,840,653
Options exercised (in shares) | shares (1,599,362)
Forfeited or expired (in shares) | shares (272,706)
Outstanding at September 30, 2017 (in shares) | shares 24,270,289
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2017, weighted average exercise price (in usd per share) | $ / shares $ 19.63
Granted, weighted average exercise price (in usd per share) | $ / shares 28.49
Options exercised, weighted average exercise price (in usd per share) | $ / shares 17.14
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 24.90
Outstanding at September 30, 2017, weighted average exercise price (in usd per share) | $ / shares $ 20.41
Class B Non-Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2017 (in shares) | shares 2,258,006
Granted (in shares) | shares 975,874
Restricted stock or RSUs vested (in shares) | shares (857,681)
Forfeited or expired (in shares) | shares (167,903)
Outstanding at September 30, 2017 (in shares) | shares 2,208,296
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2017, weighted average grant-date fair value (in usd per share) | $ / shares $ 26.07
Granted, weighted average grant date fair value (in usd per share) | $ / shares 29.31
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 26.60
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 26.10
Outstanding at September 30, 2017, weighted average grant-date fair value (in usd per share) | $ / shares $ 27.30